USPTO serial 79071885
CELLULAR GENOME POSITIONING SYSTEM (CGPS)
Reviewed by CopyMark Law Group
Reg. 3847971Status 404
- Filing date
- Status date
- Registration date
- Sep 14, 2010
- Examiner
- KIDWELL WALKER, JACLYN NOEMI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELLULAR GENOME POSITIONING SYSTEM (CGPS)?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-93230 ROMAINVILLE, FR
F-93230 ROMAINVILLE, FR
FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biotechnological and bacteriological products used in industry, science, agriculture, horticulture, namely, chemicals used for industrial purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases; chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, chemicals used for research purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological preparations for scientific purposes, namely, chemicals used for scientific purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; diagnostic preparations for scientific purposes; proteins being raw materials; reagents for the preparation or transport of biological molecules for scientific purposes | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary preparations, namely, dietetic beverages, foodstuffs and substances for medical purposes, nutritional additives for medical purposes cultures and preparations of microorganisms for medical, pharmaceutical and veterinary purposes, bacteriological preparations for medical, pharmaceutical and veterinary purposes, medicines for veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, medicines for human purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, biological preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical-pharmaceutical preparations for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites; diagnostic preparations for medical purposes | SECTION 71 - CANCELLED | — |
| 009 | Scientific apparatus and instruments used in the implementation of biochemical analysis and molecular biology techniques, namely, automated biochemical analyzer, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyzer, devices for protein-nucleic acid interaction analysis; scientific apparatus and instruments for the mapping of all molecules' biological activities; data processing apparatus; multimedia products, namely, blank magnetic, blank optical, blank image and blank sound recording media; software for recording scientific and medical data on an on-line computer database in the field of pharmaceuticals and biotechnology, for simulation and design of biological and chemical products; apparatus and instruments for non-medical diagnosis, namely, computer hardware, microscopes, spectrometers | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLECTIS
- Other trademarks owned by CELLECTIS
- Other trademarks owned by CELLECTIS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named CELLULAR GENOME POSITIONING SYSTEM (CGPS)
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 8, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 2, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 26, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 28, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 28, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 21, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 21, 2017 | C71T | CANCELLED SECTION 71 | — |
| Mar 27, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 28, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 15, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 15, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 9, 2010 | NPUB | NOTICE OF PUBLICATION | — |
| May 25, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 24, 2010 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 24, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 24, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 24, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 12, 2010 | ALIE | ASSIGNED TO LIE | — |
| May 3, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 7, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 7, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 7, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 6, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |